Fig. 2

Survival curves comparing the high and low expression of TXNIP in different tumors. A OS analyses in GEPIA2. B DFS analyses in GEPIA2. C–F OS, RFS, PPS and DMFS survival curves of breast cancer in Kaplan–Meier plotter databases (n = 1402, n = 3955, n = 414, and n = 1805, respectively). G–J OS, RFS, PFS and DSS survival curves of liver cancer in Kaplan Meier plotter databases (n = 364, n = 316, n = 370, and n = 362, respectively). K–M OS, PPS and FP survival curves of lung cancer in Kaplan Meier plotter databases (n = 1927, n = 344, and n = 982, respectively). N, O OS and PPS survival curves of gastric cancer in Kaplan Meier plotter databases (n = 881 and n = 503, respectively). HR hazard ratio, CI confidence interval, OS overall survival, DFS disease-free survival, RFS relapse-free survival, PPS post-progression survival, PFS progression-free survival, DSS disease-specific survival, DMFS distant metastasis-free survival, FP first progression